Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium-dependent phosphate transporters are membrane proteins that mediate the uptake of inorganic phosphate (Pi) into cells by coupling its transport to the movement of sodium ions (Na+). These transporters play a crucial role in maintaining phosphate homeostasis, which is essential for various physiological processes including bone mineralization, energy metabolism, and cellular signaling. The main families are SLC34 (Type II sodium-phosphate cotransporters) and SLC20 (Type III sodium-phosphate cotransporters). Key isoforms include SLC34A1 (NaPi-IIa), SLC34A2 (NaPi-IIb), SLC34A3 (NaPi-IIc), SLC20A1 (PiT1), and SLC20A2 (PiT2). Regulation occurs via Parathyroid hormone (PTH), Dietary Phosphate, Vitamin D metabolites (e.g., calcitriol), and FGF23 hormone. Mutations or dysfunctions can lead to Hypophosphatemia, Nephrolithiasis and Osteoporosis.
Inhibiting or enhancing phosphate transport across cell membranes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium-dependent phosphate transporter.